Psychopharmacologic Approaches

Neurocognitive Disorder related to Alzheimer’s

• Explain the diagnostic criteria for your assigned neurocognitive disorder.
• Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned neurocognitive disorder.
• Identify the risks of different types of therapy and explain how the benefits of the therapy that might be achieved might outweigh the risks.
• Support your rationale with references to the Learning Resources or other academic resource.

References

Oltra-Cucarella, J., Pérez-Elvira, R., Espert, R., & Sohn McCormick, A. (2016). Are cognitive interventions effective in Alzheimer’s disease? A controlled meta-analysis of the effects of bias. Neuropsychology, 30(5), 631–652. doi:10.1037/neu0000283

Hopkins, S. A. A., & Chan, D. (2016). Key emerging issues in frontotemporal dementia. Journal of Neurology, 263(2), 407–413.

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.

• Chapter 21, “Neurocognitive Disorders” (pp. 694–741)